Naslov
Liver transplantation in Croatia

Autori
Vuković, Jurica ; Novak, Milivoj ; Batinica, Stipe

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Journal of Padiatric Gastroenterology and Nutrition, Suppl 1 / - , 2004, S149-S149

Skup
ESPGHAN 37th Annual Meeting

Mjesto i datum
Pariz, Francuska, 03.07.2004. - 07.07.2004

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
liver transplantation; children
(liver transplantation; children; linear growth)

Sažetak
Skip Navigation LinksHome > June 2004 - Volume 39 - Issue > P0240 LIVER TRANSPLANTATION IN CROATIA < Previous Article | Next Article > Journal of Pediatric Gastroenterology & Nutrition: June 2004 - Volume 39 - Issue - p S149 ABSTRACTS: Poster Session Abstracts P0240 LIVER TRANSPLANTATION IN CROATIA Vukovic, J.1 ; Novak, M.1 ; Batinica, S.2 Free Access Collapse BoxAuthor Information 1Department Of Pediatrics, 2Department of Surgery, University Hospital Rebro, Zagreb, Croatia Submitted by: jvukovic@mef.hr Introduction: Pediatric liver transplantation programme has been started in Croatia since September 2001. There are many issues which are not in favour of such a programme in small country with low frequency of expected cases, lack of donor network and everlasting problems with funding.Methods: The charts of all patients who received liver transplantation to study complications of transplant surgery, immunosupression and overall survival rate were reviewed retrospectivelyResults: Between September 2001 and November 2003 8 children underwent liver transplantation (3 living-related and 5 cadaveric grafts). Patients were between the ages of 9 months and 14 years of age (mean 7, 06 yrs). Three patients received reduced left lateral segmental (II and III segment) living-related transplants. Five received cadeveric allografts (four reduced-size and one whole liver graft). Indications for transplantation included biliary atresia (n=3), alpha-1-antitrypsin deficiency(n=1), PFIC type I (n=1), Crigler-Najjar type I (n=1), choledochal cyst(n=1) and cryptogenic cirrhosis. All patients received primary tacrolimus immunosuppressive regimen. sixty- two percent of patients experienced at least 1 episode of rejection. Immidiate postoperative complications included primary nonfunction (n=1), vascular thrombosis (n=1), biliary leaks (n=4) and infections (n=9). One patient required retransplantation due to secondary vascular thrombosis and multiple fungal abscesses. She died during re-transplantation 3.5 months after first transplantation. There was one early death due to primary nonfunction. Six patients (75%) are alive at 1.5 month to 27 months post-transplant.Conclusion: Living transplantation is an effective intervention for pediatric end-stage liver disease even in small countries despite all drawbacks.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA